Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
57
days
Growth differentiation factor-15 and bleeding risk in patients with venous thromboembolism
AuthorsTimothy Hoberstorfer; Stephan Nopp; Daniel Steiner; Cornelia Englisch; Philip Kienzl; Benedikt Weber; Monika Fritzer-Szekeres; Ingrid Pabinger; Cihan Ay
AffiliationsDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Department of Dermatology, Medical University of Vienna, Vienna, Austria; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
201
days
Time-to-start of anticoagulant therapy and mortality in pulmonary embolism
AuthorsKelsey E. Bria; Brian F. Gage; Alejandra Gutierrez; Caleb J. Chiang; Jia Qi Xiong; Serena Flórez-Marqués; Cameron Upchurch; Melissa Beasley; Kristen M. Sanfilippo
AffiliationsDepartment of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA; Department of Cardiology, University of Minnesota, Minneapolis, Minnesota, USA; University of Puerto Rico-Rio Piedras, San Juan, Puerto Rico; Department of Emergency Medicine, University of Vermont Larner College of Medicine, Burlington, Vermont, USA; Department of Medicine, Division of Pulmonary and Critical Care, University of Vermont Larner College of Medicine, Burlington, Vermont, USA; Department of Medicine, St. Louis Veterans Administration Health Care System, St. Louis, Missouri, USA
212
days
Platelet triggering receptor expressed on myeloid cells–like transcript 1 regulation in healthy donors and patients at risk of bleeding and thrombosis
AuthorsAmandeep Kaur; Sidra A. Ali; Marcus Alim; Ziliang R. Chen; Vijay Bhoopalan; Samantha J. Montague; Yee Lin Thong; Mikhail Danilov; Justin J. Xia; Jordan Ross; Amanda K. Davis; Robert K. Andrews; Paul Vulliamy; Paul C. Armstrong; Philip Y.-I. Choi; Elizabeth E. Gardiner
AffiliationsDivision of Genome Science and Cancer, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia; Department of Cardiovascular Sciences, College of Medicine and Health, University of Birmingham, Birmingham, United Kingdom; Haematology Unit, The Alfred Hospital, Melbourne, Australia; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK; Clinical Haematology Unit, The Canberra Hospital, Woden, Australian Capital Territory, Australia
210
days
Nonviral delivery of a base editor enables personalized correction of hemophilia B nonsense variants in a mouse model
AuthorsUchina Hiya-Kawaguchi; Yuji Kashiwakura; Nemekhbayar Baatartsogt; Khanburged Lodoi; Tomoki Togashi; Takahiro Sato; Kosuke Tsuchida; Khishigjargal Batjargal; Morisada Hayakawa; Rikako Sato; Yusuke Sato; Tsukasa Ohmori
AffiliationsDepartment of Biochemistry, Jichi Medical University School of Medicine, Shimotsuke, Tochigi, Japan; Center for Gene Therapy Research, Jichi Medical University, Shimotsuke, Tochigi, Japan; Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, Japan
228
days
Development and validation of a risk assessment model for hospital-acquired venous thrombosis in medical in-patients with cancer
AuthorsKarlyn A. Martin; Katherine Wilkinson; Andrew Sparks; Nicholas S. Roetker; Mansour Gergi; Diego Adrianzen Herrera; Jordan K. Schaefer; Ang Li; Radhika Gangaraju; Brian L. Sprague; Chris Holmes; Neil A. Zakai
AffiliationsDepartment of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA; Department of Pathology and Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA; Department of Medical Biostatistics, Biomedical Statistics Research Core, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA; Division of Nephrology and Hypertension, Chronic Disease Research Group, Hennepin Healthcare Research Institute, University of Minnesota Medical School, Minneapolis, Minnesota, USA; Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, Michigan, USA; Department of Medicine, Section of Hematology-Oncology, Baylor College of Medicine, Houston, Texas, USA; Division of Hematology-Oncology, Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA
162
days
Subjective theory of illness, disease perception, and attitude toward anticoagulation therapy in patients with unprovoked venous thromboembolism—the qualitative Dalí study
AuthorsDaniel Steiner; Anna Kitta; Cihan Ay
AffiliationsDivision of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; Division of Palliative Medicine, Department of Medicine I, Medical University of Vienna, Vienna, Austria
166
days
Management of women with type 2B von Willebrand disease during pregnancy and postpartum: guidance from ISTH SSC subcommittees on von Willebrand factor and women’s health issues in thrombosis and hemostasis
AuthorsPredrag Miljic; Abdelrahman Noureldin; Analia Sanchez-Luceros; Rezan Abdul-Kadir; Michelle Lavin; Ross I. Baker; Robert Sidonio; Paula D. James; Maha Othman
AffiliationsClinic of Haematology, University Clinical Center of Serbia, Belgrade, Serbia; Faculty of Medicine, University of Belgrade, Belgrade, Serbia; Faculty of Medicine, Ottawa University, Ottawa, ON, Canada; Hematological Research Institute, National Academy of Medicine, Buenos Aires, Argentina; Katharine Dormandy Haemophila and Thrombosis Unit, Department of Obstetrics and Gynaecology, The Royal Free Hospital, Institute for Women’s Health, UCL, London, UK; Division of Hematology, St. James’ Hospital, Dublin, Ireland; Institute for Health Research, University of Notre Dame Australia, Perth, Australia; Clinical Research Unit, Perth Blood Institute, Perth, Australia; Hollywood Hospital Haemophilia Centre, Haematology Academic Unit, Perth, Australia; Irish–Australian Blood Collaborative Network, Dublin, Ireland; Irish–Australian Blood Collaborative Network, Perth, Australia; Emory University and Children’s Healthcare of Atlanta, Atlanta, Georgia, USA; Department of Medicine, Division of Hematology, Queen’s University, Kingston, ON, Canada; Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada; School of Baccalaureate Nursing, St. Lawrence College, Kingston, ON, Canada; Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt
28
days
Structural determination of lipid-bound factor VIII
AuthorsBassem M. Mohammed
AffiliationsEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St Louis, Missouri, USA
113
days
Novel SERPINC1 variants in hereditary antithrombin deficiency: first pathogenic deep-intronic variant, revealed by multiple genomic and transcriptomic approaches
AuthorsP. Christian Remmelzwaal; René Mulder; Jelkje J. de Boer- Bergsma; Albertus Vinke; Hilde A.M. Kooistra; Nic J.G.M. Veeger; Albertus T.J. Wierenga; Jan Jacob Schuringa; Michaël V. Lukens; Karina Meijer
AffiliationsDepartment of Haematology, University Medical Centre Groningen, Groningen, Netherlands; Department of Genetics, University of Groningen, University Medical Centre Groningen, Netherlands; Department of Laboratory Medicine, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands; Department of Epidemiology, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands
161
days
Wrapping it up: structural basis of ADAMTS-13 global latency
AuthorsNorman Geist; Quintijn Bonnez; Karen Vanhoorelbeke; Mihaela Delcea
AffiliationsDepartment of Biophysical Chemistry, Institute of Biochemistry, University of Greifswald, Greifswald, Germany; Laboratory for Thrombosis Research, KU Leuven Kulak, Kortrijk, Belgium; DZHK (German Centre for Cardiovascular Research), Partner Site North, Greifswald, Germany
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days